Black FridayUp to 80% OFF
Pfizer Inc.Pfizer Inc.Pfizer Inc.

Pfizer Inc.

No trades
See on Supercharts
OverviewFinancialsNewsIdeasMindsTechnicalsForecastsSeasonalsBondsETFs

Chart


Full chart

Key facts today


The U.S. will announce negotiated prices for 15 costly drugs under Medicare, including Pfizer's Eliquis, likely cutting costs by 36% and saving about $8.5 billion.
Analyze the impactAnalyze the impact

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪545.22 T‬ COP
Dividend yield (indicated)
6.82%
Price to earnings Ratio (TTM)
20
Basic EPS (TTM)
6,760 COP
Net income (FY)
‪35.33 T‬ COP
Revenue (FY)
‪280.30 T‬ COP
Shares float
‪5.68 B‬
Beta (1Y)
0.57

Employees


Employees (FY)
‪81 K‬
Change (1Y)
‪−7 K‬ −7.95%
Revenue / Employee (1Y)
‪3.46 B‬ COP
Net income / Employee (1Y)
‪436.18 M‬ COP

About Pfizer, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Albert Bourla
Website
pfizer.com
Headquarters
New York
Founded
1849
ISIN
US7170811035
FIGI
BBG001BJ6532
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Check out other big names from the same industry as PFE.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


XS173899459
Pfizer Inc. 2.735% 15-JUN-2043
Yield to maturity
5.90%
Maturity date
Jun 15, 2043
P
PFE5588844
Pfizer Investment Enterprises Pte. Ltd. 5.34% 19-MAY-2063
Yield to maturity
5.69%
Maturity date
May 19, 2063
PFE6238667
Pfizer Inc. 5.7% 15-NOV-2065
Yield to maturity
5.65%
Maturity date
Nov 15, 2065
P
PFE5588843
Pfizer Investment Enterprises Pte. Ltd. 5.3% 19-MAY-2053
Yield to maturity
5.52%
Maturity date
May 19, 2053
PFE6238665
Pfizer Inc. 5.6% 15-NOV-2055
Yield to maturity
5.51%
Maturity date
Nov 15, 2055
US717081ED1
Pfizer Inc. 4.125% 15-DEC-2046
Yield to maturity
5.44%
Maturity date
Dec 15, 2046
US717081EV1
Pfizer Inc. 4.0% 15-MAR-2049
Yield to maturity
5.43%
Maturity date
Mar 15, 2049
US717081FA6
Pfizer Inc. 2.7% 28-MAY-2050
Yield to maturity
5.42%
Maturity date
May 28, 2050
US717081EK5
Pfizer Inc. 4.2% 15-SEP-2048
Yield to maturity
5.40%
Maturity date
Sep 15, 2048
US717081DE0
Pfizer Inc. 4.3% 15-JUN-2043
Yield to maturity
5.35%
Maturity date
Jun 15, 2043
P
PFE5588591
Pfizer Investment Enterprises Pte. Ltd. 5.11% 19-MAY-2043
Yield to maturity
5.33%
Maturity date
May 19, 2043

See all PFE bonds 

ETFs


VTI
Vanguard Total Stock Market ETF
Weight
0.21%
Market value
‪4.40 B‬
USD
VOO
Vanguard S&P 500 ETF
Weight
0.24%
Market value
‪3.50 B‬
USD
IVV
iShares Core S&P 500 ETF
Weight
0.25%
Market value
‪1.83 B‬
USD
SPY
SPDR S&P 500 ETF
Weight
0.25%
Market value
‪1.73 B‬
USD
SPY
SPDR S&P 500 ETF Trust
Weight
0.25%
Market value
‪1.73 B‬
USD
VTV
Vanguard Value ETF
Weight
0.61%
Market value
‪1.27 B‬
USD
XLV
Health Care Select Sector SPDR Fund
Weight
2.54%
Market value
‪1.02 B‬
USD
VYM
Vanguard High Dividend Yield Index ETF
Weight
0.68%
Market value
‪548.71 M‬
USD
VHT
Vanguard Health Care ETF
Weight
2.27%
Market value
‪421.98 M‬
USD
DVY
iShares Select Dividend ETF
Weight
1.93%
Market value
‪401.88 M‬
USD
FDL
First Trust Morningstar Dividend Leaders Index Fund
Weight
6.62%
Market value
‪395.91 M‬
USD

Explore more ETFs 

Sparks


Curated watchlists where PFE is featured.

See all sparks 

Frequently Asked Questions


The current price of PFE is 97,860 COP — it has increased by 1.16% in the past 24 hours. Watch Pfizer Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BVC exchange Pfizer Inc. stocks are traded under the ticker PFE.
PFE stock has risen by 3.84% compared to the previous week, the month change is a 2.51% rise, over the last year Pfizer Inc. has showed a −14.46% decrease.
We've gathered analysts' opinions on Pfizer Inc. future price: according to them, PFE price has a max estimate of 137,490.49 COP and a min estimate of 91,254.75 COP. Watch PFE chart and read a more detailed Pfizer Inc. stock forecast: see what analysts think of Pfizer Inc. and suggest that you do with its stocks.
PFE reached its all-time high on Dec 19, 2022 with the price of 252,340 COP, and its all-time low was 40,840 COP and was reached on Nov 19, 2012. View more price dynamics on PFE chart.
See other stocks reaching their highest and lowest prices.
PFE stock is 1.82% volatile and has beta coefficient of 0.57. Track Pfizer Inc. stock price on the chart and check out the list of the most volatile stocks — is Pfizer Inc. there?
Today Pfizer Inc. has the market capitalization of ‪556.03 T‬, it has increased by 4.77% over the last week.
Yes, you can track Pfizer Inc. financials in yearly and quarterly reports right on TradingView.
Pfizer Inc. is going to release the next earnings report on Feb 3, 2026. Keep track of upcoming events with our Earnings Calendar.
PFE earnings for the last quarter are ‪3.41 K‬ COP per share, whereas the estimation was ‪2.48 K‬ COP resulting in a 37.52% surprise. The estimated earnings for the next quarter are ‪2.29 K‬ COP per share. See more details about Pfizer Inc. earnings.
Pfizer Inc. revenue for the last quarter amounts to ‪65.31 T‬ COP, despite the estimated figure of ‪64.70 T‬ COP. In the next quarter, revenue is expected to reach ‪66.42 T‬ COP.
PFE net income for the last quarter is ‪13.89 T‬ COP, while the quarter before that showed ‪11.78 T‬ COP of net income which accounts for 17.93% change. Track more Pfizer Inc. financial stats to get the full picture.
Yes, PFE dividends are paid quarterly. The last dividend per share was ‪1.63 K‬ COP. As of today, Dividend Yield (TTM)% is 6.65%. Tracking Pfizer Inc. dividends might help you take more informed decisions.
Pfizer Inc. dividend yield was 6.37% in 2024, and payout ratio reached 120.11%. The year before the numbers were 5.73% and 441.41% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 26, 2025, the company has ‪81 K‬ employees. See our rating of the largest employees — is Pfizer Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pfizer Inc. EBITDA is ‪103.56 T‬ COP, and current EBITDA margin is 36.93%. See more stats in Pfizer Inc. financial statements.
Like other stocks, PFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pfizer Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pfizer Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pfizer Inc. stock shows the sell signal. See more of Pfizer Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.